about
Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and DifferencesRole of phosphate and calcium stores in muscle fatigueACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure.Age-associated disruption of molecular clock expression in skeletal muscle of the spontaneously hypertensive rat.Myofilament protein alterations promote physical disability in aging and disease.Resistance training improves hemodynamic function, collagen deposition and inflammatory profiles: experimental model of heart failure.Low-level laser therapy improves the inflammatory profile of rats with heart failure.Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training.Skeletal muscle arteriolar function following myocardial infarction: Analysis of branch-order effects.Metabolic myopathy in heart failure.Living in a box or call of the wild? Revisiting lifetime inactivity and sarcopeniaMembrane excitability, weakness, and fatigue.Lack of β2 -adrenoceptors aggravates heart failure-induced skeletal muscle myopathy in miceAbnormalities of calcium handling proteins in skeletal muscle mirror those of the heart in humans with heart failure: a shared mechanism?Intact skeletal muscle mitochondrial enzyme activity but diminished exercise capacity in advanced heart failure patients on optimal medical and device therapy.Chronic inflammation is associated with low physical function in older adults across multiple comorbidities.Analysis of Skeletal Muscle Torque Capacity and Circulating Ceramides in Patients with Advanced Heart Failure.High-intensity strength training improves function of chronically painful muscles: case-control and RCT studies.Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function.Creatine phosphate: pharmacological and clinical perspectives.Metabolic and structural impairment of skeletal muscle in heart failure.Skeletal Muscle Changes in Chronic Cardiac Disease and Failure.Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure.Aerobic exercise improves the inflammatory profile correlated with cardiac remodeling and function in chronic heart failure rats.Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles.Muscle dysfunction during exercise of a single skeletal muscle in rats with congestive heart failure is not associated with reduced muscle blood supply.Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockade.Na+-K+-ATPase properties in rat heart and skeletal muscle 3 mo after coronary artery ligation.Temperature-dependent skeletal muscle dysfunction in rats with congestive heart failure.Functional capacity in a rat model of heart failure: impact of myocardial infarct size.Experimental Evidences Supporting the Benefits of Exercise Training in Heart Failure.Contractile properties of in situ perfused skeletal muscles from rats with congestive heart failure.Effect of contrasting physical exercise interventions on rapid force capacity of chronically painful muscles
P2860
Q26767412-FE4C7974-35B0-4D37-8C5A-3D025B192A30Q28363148-5F7D5033-7E0B-4512-A326-93A294576A80Q33962753-B252B3F4-4A1F-4120-888D-38588DFB1CE7Q34072641-D6FEA0AE-B834-4C22-967C-83482506CF35Q34224403-C5759452-3F51-4286-8290-B0E33AC0CE14Q34395152-B604052D-848F-4E7C-9CC9-DFB09F9D76A5Q34398672-FF560BF0-C161-4FD5-AE8D-914CF41AB09AQ34603843-12B635D6-0BF7-47A3-9E3F-B79FD07537F3Q34810070-232C1E91-2FFD-4300-8EFE-5F8786D7A300Q34882722-9C6C0E4E-1845-4F34-BDE0-A675D1D33969Q35222190-1E651042-A401-47F7-B53A-28F465DEC509Q35806224-7AEDE713-B67E-4D69-9071-48A30CC20853Q35867936-B29B7CBE-A61E-4282-AAC1-1793039CE567Q36222339-9E20BADD-82A1-4D2E-A85E-4F864F89F231Q37008960-499F8961-30F1-4187-B7F0-41FDEF247D2EQ37132103-AA38F106-4920-4FB1-8F68-D82CD000F2AFQ37140401-42B79272-0F35-4780-9092-F48E1A3B0B45Q37636109-2F439718-CBAF-4FB4-A30D-8B0C716F7FD8Q37940294-63E02025-766B-4A4F-B9E6-3048B68875EDQ37980661-9ECBA745-FF9E-4B33-8819-8763D6750A25Q38052031-B5FACD67-F190-4825-89B3-8AB5A7B7A4A5Q38596709-700D80A4-7D71-46E2-AD31-F064C5264731Q38979963-62327969-08C8-4264-93BA-AE81FD9286CEQ42142166-641402AE-EE14-412A-840B-89C9B2347DCCQ44489944-E15B379D-D78E-4344-886A-17C85223DBEAQ44924048-1A7F60D6-451A-44E4-A630-7A39ED722048Q45076005-D1856FB1-8236-45DE-90A3-1E434A9F75F2Q46427746-359F6B48-CF60-4435-B2D2-ACEDE3709CC0Q46525260-F36E0701-34DB-4C7F-8B59-5FF1784BC873Q47192112-DB887BAF-9EDD-4687-A8D7-94615E41D1B7Q48023234-76811F64-78CA-47CF-BA05-7E767C9EE9C8Q49140605-08CBA19B-FFAD-4B04-B30D-0493C8DC74E9Q59329567-323DF57F-8018-4E81-9E69-D0C52DBD132F
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Skeletal muscle disorders in heart failure.
@ast
Skeletal muscle disorders in heart failure.
@en
Skeletal muscle disorders in heart failure.
@nl
type
label
Skeletal muscle disorders in heart failure.
@ast
Skeletal muscle disorders in heart failure.
@en
Skeletal muscle disorders in heart failure.
@nl
prefLabel
Skeletal muscle disorders in heart failure.
@ast
Skeletal muscle disorders in heart failure.
@en
Skeletal muscle disorders in heart failure.
@nl
P2860
P1433
P1476
Skeletal muscle disorders in heart failure.
@en
P2093
Schiøtz Thorud HM
P2860
P304
P356
10.1046/J.1365-201X.2001.00830.X
P577
2001-03-01T00:00:00Z